Ashutosh Kumar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ashutosh Kumar has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Ankita Jaiswal
Department of Anaesthesia and Critical Care, Sarojini Naidu Medical College, Agra, India
2 shared publications - Kanika Gupta
Department of Anaesthesiology and Critical Care, All India Institute of Medical Sciences, Rishikesh, India
2 shared publications - Mukesh Mohan Gupta
Department of Neuroanaesthesia and Neurocritical Care, Aakash Hospital, New Delhi, India
2 shared publications - Sandeep Dey
Department of Neuroanaesthesia and Neurocritical Care, Paras Hospital, Gurugram, India
2 shared publications - Stuti Bhamri
Department of Neuroanaesthesia and Neurocritical Care, National Institute of Mental Health and Neurosciences, Bangalore, India
2 shared publications
Latest Publications
- Open Access
- 31 October 2026
- Published by Asian Spine Journal (ASJ) in Asian Spine Journal
- Vol. 20 (5) , 866-875
Comparison of dexmedetomidine and morphine versus plain ropivacaine 0.2% for myofascial infiltration in thoracolumbar spinal fusion: a double-blind randomized trial
Study Design: Prospective double-blinded randomized controlled trial.Purpose: This study aimed to compare the effect of adding dexmedetomidine or morphine to 0.2% ropivacaine on total postoperative opioid consumption and to compare time to first rescue analgesia, Visual Analog Scale (VAS) scores, and side effect profiles between groups.Overview of Literature: Spine fusion surgery involves cutting or retracting the paraspinal muscles, causing moderate to severe postoperative pain. Neuroanesthesia aims to ensure adequate safety and analgesia, thereby facilitating immediate postoperative neurological examination, mobilization, and early hospital discharge.Methods: A double-blinded, randomized controlled trial was conducted involving 66 consenting patients upon obtaining approval from the Institutional Ethics Committee. Patients were randomly allocated into three groups (ropivacaine [R], ropivacaine with dexmedetomidine [RD], and ropivacaine with morphine [RM], 22 patients per group). The operating surgeon administered the allocated study drug at the end of surgery according to group assignment.Results: All the groups were comparable in terms of demographic characteristics, American Society of Anesthesiologists class, and number of spine segments operated on. Mean total postoperative opioid consumption, time to first request for rescue analgesia, and total VAS score were significantly lower in groups RD and RM compared with group R, and in group RM compared with group RD. Similar results were observed when patients were analyzed based on the number of spinal segments operated on.Conclusions: Morphine as an adjuvant to ropivacaine showed superior efficacy compared with dexmedetomidine–ropivacaine or ropivacaine alone in patients undergoing elective thoracolumbar spine fusion surgery.
- 31 October 2026
- Published by Asian Spine Journal (ASJ) in Asian Spine Journal
- Vol. 20 (5) , 866-875
Open AccessComparison of dexmedetomidine and morphine versus plain ropivacaine 0.2% for myofascial infiltration in thoracolumbar spinal fusion: a double-blind randomized trial
Study Design: Prospective double-blinded randomized controlled trial.Purpose: This study aimed to compare the effect of adding dexmedetomidine or morphine to 0.2% ropivacaine on total postoperative opioid consumption and to compare time to first rescue analgesia, Visual Analog Scale (VAS) scores, and side effect profiles between groups.Overview of Literature: Spine fusion surgery involves cutting or retracting the paraspinal muscles, causing moderate to severe postoperative pain. Neuroanesthesia aims to ensure adequate safety and analgesia, thereby facilitating immediate postoperative neurological examination, mobilization, and early hospital discharge.Methods: A double-blinded, randomized controlled trial was conducted involving 66 consenting patients upon obtaining approval from the Institutional Ethics Committee. Patients were randomly allocated into three groups (ropivacaine [R], ropivacaine with dexmedetomidine [RD], and ropivacaine with morphine [RM], 22 patients per group). The operating surgeon administered the allocated study drug at the end of surgery according to group assignment.Results: All the groups were comparable in terms of demographic characteristics, American Society of Anesthesiologists class, and number of spine segments operated on. Mean total postoperative opioid consumption, time to first request for rescue analgesia, and total VAS score were significantly lower in groups RD and RM compared with group R, and in group RM compared with group RD. Similar results were observed when patients were analyzed based on the number of spinal segments operated on.Conclusions: Morphine as an adjuvant to ropivacaine showed superior efficacy compared with dexmedetomidine–ropivacaine or ropivacaine alone in patients undergoing elective thoracolumbar spine fusion surgery.
- Open Access
- 30 June 2026
- Published by Asian Spine Journal (ASJ) in Asian Spine Journal
- Vol. 20 (3) , 620-621
Response to the letter to the editor: Methodological considerations on “Comparison of dexmedetomidine and morphine versus plain ropivacaine 0.2% for myofascial infiltration in thoracolumbar spinal fusion: a double-blind randomized trial”
- 30 June 2026
- Published by Asian Spine Journal (ASJ) in Asian Spine Journal
- Vol. 20 (3) , 620-621
Open AccessResponse to the letter to the editor: Methodological considerations on “Comparison of dexmedetomidine and morphine versus plain ropivacaine 0.2% for myofascial infiltration in thoracolumbar spinal fusion: a double-blind randomized trial”